The potential use of selective 5-HT_2C agonists in treating obesity

By Smith Brian M   Thomsen William J   Grottick Andrew J  

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 3, 2006-03 ,pp. : 257-266

Informa Healthcare

Access to resources Recommend Favorite

Potential anxiolytic properties of R-(+)-8-OSO 2 CF 3 -PAT, a 5-HT 1A receptor agonist

By Barf T.   Korte S.M.   Korte-Bouws G.   Sonesson C.   Damsma G.   Bohus B.   Wikstrom H.  

European Journal of Pharmacology, Vol. 297, Iss. 3, 1996-02 ,pp. : 205-211

Elsevier

Access to resources Recommend Favorite

SB-236057, a selective 5-HT 1B receptor inverse agonist, blocks the 5-HT human terminal autoreceptor

By Middlemiss D.N.   Gothert M.   Schlicker E.   Scott C.M.   Selkirk J.V.   Watson J.   Gaster L.M.   Wyman P.   Riley G.   Price G.W.  

European Journal of Pharmacology, Vol. 375, Iss. 1, 1999-06 ,pp. : 359-365

Elsevier

Access to resources Recommend Favorite

The selective 5-HT2A receptor inverse agonist ACP 103 may be beneficial for Parkinson's disease patients with treatment-induced psychosis

By  

Reactions Weekly, Vol. 1, Iss. 1097-1098, 2006-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

5-HT2A Inverse-Agonists for the Treatment of Insomnia

By  

Current Topics in Medicinal Chemistry, Vol. 8, Iss. 11, 2008-07 ,pp. : 969-976

Bentham Science Publishers

Access to resources Recommend Favorite